CNP Clinphone

RNS Number:8693L
ClinPhone plc
16 January 2008


16 January 2008                                                      LSE : CNP



                                 ClinPhone plc

                      Q3 2007 Interim Management Statement


ClinPhone plc ("ClinPhone" or the "Company"), the leading provider of technology
for clinical trials, today provides an Interim Management Statement for the
third quarter (ended 30 November 2007).


Highlights



*   Q3 revenues up 18% y/y on a constant currency basis; reported revenues 
    up 13%


*   Order book increased by 7% on constant currency basis to �51.3 million


*   Customer base broadened through 39 new customer wins


*   Full year 2008 results expected to be materially ahead of management
    expectations (see Outlook section below)





Since the announcement of the Company's interim results on 29 October 2007,
ClinPhone has made good progress. The operational restructuring plan implemented
following the difficulties encountered in the summer of 2007, has resulted in a
material enhancement of the financial performance of the Company. ClinPhone also
appointed a Chief Operations Officer in the Quarter ended 30 November 2007 to
implement further improvements in the Company's operations.



Group Revenues



Group revenues for the quarter were up 18% on the quarter ended 30 November 2006
on a constant currency basis. Revenues continue to be significantly impacted by
the US$:GBP exchange rate and therefore were up 13% on a reported basis.



Order Book



Despite the order book being impacted by �4 million of cancellations in the
summer of 2007, at constant exchange rates the order book has increased by 7% to
�51.3 million (Quarter ended 30 November 2006: �49.1 million).



Underlying proposal activity remains strong.  Whilst the weakening of the US
dollar and a change in business mix has resulted in the average order value
being lower than the historic average, the customer base supporting the order
book has been strengthened through 39 new customers wins in the quarter.



ClinPhone has also won contracts to deliver a number of integrated solutions to
customers containing a range of different component products and services.
ClinPhone is already a market leader in the provision of integrated solutions
for clinical trials and further product developments are being progressed that
will increase the value of these solutions to our customers.



Live Trials



Activity in the quarter saw the Company add a further 51 trials to its systems
(Quarter ended 30 November 2006: 62), increasing the average number of live
trials to 531 for the quarter (Quarter ended 30 November 2006: 472).



Service revenues from the EDC product set, acquired with the DataLabs
acquisition in November 2006, continue to grow quickly.  Business and delivery
operations have been scaled successfully in order to meet this growing demand
and to ensure that these services are managed effectively for our clients.



Outlook



The operational issues that affected the business over the summer have been
resolved and ClinPhone is working with the small number of customers that were
affected to restore their confidence in the service provided.



Despite the lower average order value, the overall volume of new business has
been higher than anticipated.  Assuming that the US$:GBP exchange rate averages
$2.00:�1 for the remainder of the year, results for the financial year ending 29
February 2008 are now expected to be materially ahead of management's
expectations.



Looking forward towards the following financial year ending 28 February 2009,
ClinPhone's order book remains strong.  As the customer base has grown and
diversified to include a range of smaller clients with shorter duration trials
and who are capable of making faster decisions on the use of our products, so
the length of the order book has shortened enabling the Company to deliver a
higher proportion of the order book in the next financial year.  With 70% of the
clinical trials market still using paper based systems, demand for clinical
technology services is expected to continue to exhibit strong growth.



Steve Kent, Chief Executive of ClinPhone, said:



"Given the difficulties experienced during the summer, I am particularly pleased
with the resilience that the business has shown during the past six months.



Whilst the majority of the Company and its core offerings were not impacted, the
restructuring plan to address the small number of operational issues that did
occur has been successfully implemented more rapidly than we expected at the
time of our October statement.



The Company has learnt from the experience of last summer, operational
improvements have been made and with a number of new development activities in
the early stages of deployment showing good promise, ClinPhone enters 2008 in a
strong position."







Enquiries:


ClinPhone plc                                               +44 (0) 115 955 7333
Steve Kent, Chief Executive Officer
Scott Brown, Chief Financial Officer

Financial Dynamics                                          +44 (0) 20 7831 3113
David Yates
Ben Brewerton





About ClinPhone

ClinPhone plc is a specialist Clinical Technology Organization (CTO) working
with the leading global biotech and pharmaceutical organizations.  With its
corporate headquarters in Nottingham, UK, ClinPhone is the largest and most
accomplished CTO with experience in over 1950 clinical trials spanning 88
countries and 71 languages. The company's solutions enable its clients to manage
their clinical trials more effectively through the use of technology. Building
on its telephone and web-based randomization and medication management
expertise, ClinPhone can offer a wide range of innovative products covering all
aspects of a clinical trial, including Electronic Patient Reported Outcomes
(ePRO), Interactive Voice and Web Response (IVR and IWR), Patient Recruitment
Solutions, Electronic Data Capture (EDC) and Clinical Trial Management Software
(CTMS).






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCUNABRWORAARR

Clinphone (LSE:CNP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Clinphone (LSE:CNP)
Historical Stock Chart
From Jul 2023 to Jul 2024